Model DetailsIntestine tumor
Model Name |
Intestine tumor | Strain |
C57BL/6J-ApcMin/+ |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
intestine tumor lesion • intestine tumor • Intestinal tumor • intestinal tumor |
Strain Synonyms |
C57BL/6J-APCMin/+ • C57BL/6J-ApcMin/J • APCmin/+ • C57BL/6J/Min/+ • C57BL/6J-ApcMin • ApcMin • C57BL/6 ApcMin/+ • C57BL/6J-Min • B6-ApcMin/Apc+ • C57Bl/6J-Min+ • ApcMin • C57BL/6J-ApcMin/+ • Min C57BL/6J • C57BL/6J-APCmin/+ • C57BL/6J Min /+ • ApcMin/+ • Apc+/- • Apc+/- Msh2+/+ • APCMin/+ • Min • C57BL/6J ApcMin/+ • C57Bl/6-Min • adenomatous polyposis coliMin/+ • C57BL/6J-Min/+ • APCMin/+ • C57BL/6J-ApcMin • C57BL/6J-ApcMin/+ • C57BL/6J APCMin/+ • C57BL/6J Min • B6-ApcMin • C57Bl/6-Min/+ • C57BL/6-Min • C57BL/6J-Min/+ • ApcMin/+ • C57BL/6-Min • ApcMin/+ • C57BL/6J-APCMin/+ • C57Bl/6J-Min/+ • Min/+ • ApcMin • ApcMin heterozygous • Min/+ • ApcMin • C57BL/6J-ApcMin/+ • C57Bl/6JMin/+ • Apcmin • multiple intestinal neoplasia • C57BL/6J ApcMin/+ • ApcMin/Apc+ • C57BL/6J Min/+ • B6 Min/+ • Min • C57BL/6J Min • APCMin/+ • C57BL/6J-ApcMin/J • Min/+ C57BL/6J • ApcMin/+ • APCMin/+ • C57BL/6J Apcmin • C57BL/6J/-ApcMin |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Intestine | Unspecified |
100% |
|
Dudley ME, Int J Cancer 1996 Jan 17;65(2):249-53 | |
| Intestine | Unspecified |
100% (14 of 14 mice) |
~17 weeks |
|
Wilson CL, Proc Natl Acad Sci U S A 1997 Feb 18;94(4):1402-7 |
| Intestine | Female |
100% |
<123 days |
|
Moser AR, Cancer Res 2001 Apr 15;61(8):3480-5 |
| Intestine | Mixed Population |
observed |
99-104 days |
|
Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63 |
| Intestine | Mixed Population |
observed |
99-104 days |
|
Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63 |
| Intestine | Female |
observed |
110 days |
|
Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60 |
| Intestine | Male |
observed |
14 weeks |
|
Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7 |
| Intestine | Male |
observed |
14 weeks |
|
Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7 |
| Intestine | Mixed Population |
observed |
13 weeks |
|
Barnes CJ, Gastroenterology 1998 May;114(5):873-7 |
| Intestine | Unspecified |
observed |
3 months |
|
Oster H, Cancer Res 2006 Jul 15;66(14):6955-63 |
| Intestine | Unspecified |
observed |
6-7 months |
|
Zheng W, Int J Cancer 2012 Jan 1;130(1):10-9 |
| Intestine | Unspecified |
observed |
|
Maywald RL, Proc Natl Acad Sci U S A 2015 May 12;112(19):E2487-96 | |
| Intestine | Unspecified |
observed |
|
Wang X, Oncogene 2017 Aug 31;36(35):4987-4996 | |
| Intestine | Unspecified |
observed |
|
Heuberger J, Life Sci Alliance 2019 Feb;2(1):e201800173 | |
| Intestine | Unspecified |
observed |
|
Qi C, Int J Biol Sci 2015;11(6):679-87 | |
| Intestine | Unspecified |
observed |
|
Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39): | |
| Intestine | Unspecified |
observed |
16 weeks |
|
You S, Cancer Cell 2024 Aug 12;42(8):1415-1433.e12 |
| Intestine | Unspecified |
observed |
|
You S, Cancer Cell 2024 Aug 12;42(8):1415-1433.e12 | |
| Intestine | Unspecified |
observed |
4 months |
|
You S, Cancer Cell 2024 Aug 12;42(8):1415-1433.e12 |